These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5337107)

  • 1. Comparison of antimetabolites in the treatment of breast and colon cancer.
    JAMA; 1967 May; 200(9):770-8. PubMed ID: 5337107
    [No Abstract]   [Full Text] [Related]  

  • 2. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 3. Schedule-dependent cytotoxicity of methotrexate and 5-fluorouracil in human colon and breast tumor cell lines.
    Benz C; Schoenberg M; Choti M; Cadman E
    J Clin Invest; 1980 Nov; 66(5):1162-5. PubMed ID: 7430346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of treatment of malignant tumors with ftorafur.
    Blokhina NG; Vozny EK; Garin AM
    Cancer; 1972 Aug; 30(2):390-2. PubMed ID: 5051663
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
    Hill GJ; Larsen RR
    Oncology; 1972; 26(2):206-22. PubMed ID: 4626137
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma.
    Taylor SG; Desai SA; DeWys WD
    Cancer Treat Rep; 1978 Aug; 62(8):1203-5. PubMed ID: 356978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G; Germiniani R; Lavorato F
    Minerva Med; 1977 Mar; 68(13):835-7. PubMed ID: 321990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of treatment with 5-fluorouracil and folinic acid in patients with carcinoma of the large intestine].
    Nastasi G; Sala L; Romano AM; Nucera D; Anselmetti L; Castoldi O; Crema F; Pasotti D
    Medicina (Firenze); 1988; 8(2):175-8. PubMed ID: 2852292
    [No Abstract]   [Full Text] [Related]  

  • 11. FIVB--a new combination of drugs in the treatment of cancer.
    Van Eden EB; Falkson G; Van der Merwe AM; Van Dyk JJ; Falkson HC
    S Afr Med J; 1973 Jun; 47(23):982-4. PubMed ID: 4714282
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential 5-fluorouracil and hydroxyurea therapy for metastatic colorectal adenocarcinoma.
    Krein BM; Conroy JF; Brodsky I
    J Am Osteopath Assoc; 1978 Apr; 77(8):604-5. PubMed ID: 649446
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination of antimetabolites and alkylating agents in the treatment of advanced breast cancer].
    Germiniani R; Pipino G; Lavorato F; Bressani Doldi S
    Minerva Med; 1977 Mar; 68(13):831-4. PubMed ID: 321989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy with four drugs for stage 2 breast cancer.
    Wheeler TK; Edelstyn GA; Bates TS; Brinkley D; Evans RG; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler TK
    Eur J Cancer (1965); 1980; Suppl 1():161-3. PubMed ID: 7032926
    [No Abstract]   [Full Text] [Related]  

  • 17. Low dosage methotrexate (NSC-740) and cyclophosphamide (NSC 26271) for solid tumors.
    Foley JF; Lemon HM; Miller D
    Cancer Chemother Rep; 1970 Feb; 54(1):41-6. PubMed ID: 4334084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of cancer of the rectum and the colon].
    Meyza J
    Pol Tyg Lek; 1970 Nov; 25(46):1757-9. PubMed ID: 4249465
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III study comparing the clinical utility of four regimens of 5-fluorouracil: a preliminary report.
    Ansfield F; Klotz J; Nealon T; Ramirez G; Minton J; Hill G; Wilson W; Davis H; Cornell G
    Cancer; 1977 Jan; 39(1):34-40. PubMed ID: 318916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.